1. Home
  2. AVTX vs KOPN Comparison

AVTX vs KOPN Comparison

Compare AVTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • KOPN
  • Stock Information
  • Founded
  • AVTX 2011
  • KOPN 1984
  • Country
  • AVTX United States
  • KOPN United States
  • Employees
  • AVTX N/A
  • KOPN 144
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • AVTX Health Care
  • KOPN Technology
  • Exchange
  • AVTX Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • AVTX 88.4M
  • KOPN 277.5M
  • IPO Year
  • AVTX 2015
  • KOPN 1992
  • Fundamental
  • Price
  • AVTX $8.18
  • KOPN $1.82
  • Analyst Decision
  • AVTX Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • AVTX 4
  • KOPN 4
  • Target Price
  • AVTX $33.00
  • KOPN $2.63
  • AVG Volume (30 Days)
  • AVTX 65.8K
  • KOPN 10.3M
  • Earning Date
  • AVTX 03-28-2025
  • KOPN 03-13-2025
  • Dividend Yield
  • AVTX N/A
  • KOPN N/A
  • EPS Growth
  • AVTX N/A
  • KOPN N/A
  • EPS
  • AVTX N/A
  • KOPN N/A
  • Revenue
  • AVTX $820,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • AVTX N/A
  • KOPN $21.18
  • Revenue Next Year
  • AVTX N/A
  • KOPN $13.57
  • P/E Ratio
  • AVTX N/A
  • KOPN N/A
  • Revenue Growth
  • AVTX N/A
  • KOPN 0.60
  • 52 Week Low
  • AVTX $4.17
  • KOPN $0.56
  • 52 Week High
  • AVTX $34.46
  • KOPN $2.82
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 52.50
  • KOPN 61.10
  • Support Level
  • AVTX $7.82
  • KOPN $1.57
  • Resistance Level
  • AVTX $8.50
  • KOPN $1.99
  • Average True Range (ATR)
  • AVTX 0.78
  • KOPN 0.21
  • MACD
  • AVTX 0.20
  • KOPN 0.02
  • Stochastic Oscillator
  • AVTX 73.11
  • KOPN 69.23

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: